Valuation : Alcon Inc.

Market Cap 33.36B 170B 28.68B 26.98B 24.62B 45.95B 3,163B 46.19B 320B 124B 1,616B 125B 123B 5,144B P/E 2026 *
38.8x
P/E 2027 * 24.6x
Enterprise Value 35.9B 183B 30.87B 29.04B 26.5B 49.46B 3,404B 49.72B 344B 133B 1,740B 135B 132B 5,536B EV / Sales 2026 *
3.24x
EV / Sales 2027 * 2.96x
Free-Float
97.34%
Yield 2026 *
0.54%
Yield 2027 * 0.6%
1 day+6.98%
1 month+6.98%
3 months+12.19%
6 months-7.95%
Current year-15.56%
1 month 38
Extreme 38
38
Current year 30.88
Extreme 30.88
43.96
1 year 30.88
Extreme 30.88
45
3 years 30.88
Extreme 30.88
56.76
5 years 30.35
Extreme 30.35
56.76
10 years 30.35
Extreme 30.35
56.76
Manager TitleAgeSince
Chief Executive Officer 60 2018-06-30
Director of Finance/CFO 58 2019-04-07
Chief Tech/Sci/R&D Officer - 2024-12-31
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 2018-06-30
Director/Board Member 63 2019-01-31
Change 5-day change 1-year change 3-year change Capi.($)
+6.98%-.--% - - 34.04B
+0.71%-6.70%-42.37%-13.71% 79.39B
-2.00%-4.68%-12.89%-24.38% 34.04B
-2.73%-2.30%-1.60%-22.64% 13.57B
+1.13%+5.03% - - 12.65B
+2.57%-1.92%-4.73%+625.95% 2.64B
+0.64%-0.36%-38.44%-57.43% 1.46B
-0.07%+7.67% - - 968M
-0.92%-5.88%+16.41%+1.48% 924M
-0.88%-1.84%-36.50%-20.69% 887M
Average +0.57%-1.27%-17.16%+69.80% 16.28B
Weighted average by Cap. +1.20%-4.56%-29.42%-5.05%

Financials

2026 *2027 *
Net sales 11.09B 56.37B 9.53B 8.97B 8.19B 15.28B 1,051B 15.36B 106B 41.12B 537B 41.64B 40.73B 1,710B 11.77B 59.85B 10.12B 9.52B 8.69B 16.22B 1,116B 16.3B 113B 43.66B 571B 44.21B 43.25B 1,815B
Net income 764M 3.88B 657M 618M 564M 1.05B 72.45B 1.06B 7.32B 2.83B 37.03B 2.87B 2.81B 118B 1.26B 6.4B 1.08B 1.02B 929M 1.73B 119B 1.74B 12.07B 4.67B 61B 4.73B 4.62B 194B
Net Debt 2.54B 12.94B 2.19B 2.06B 1.88B 3.51B 241B 3.52B 24.39B 9.44B 123B 9.56B 9.35B 392B 1.45B 7.37B 1.25B 1.17B 1.07B 2B 137B 2.01B 13.9B 5.38B 70.26B 5.44B 5.33B 224B
Logo Alcon Inc.
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
25,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
69.01USD
Average target price
91.40USD
Spread / Average Target
+32.45%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!